Hunan Fangsheng Pharmaceutical Co., Ltd.SSE: 603998

Announcement on Proposed Withdrawal from an M&A Fund and Related Party Transactions

· Issued by Hunan Fangsheng Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

Summary by 6ix AI

Hunan Fangsheng Pharmaceutical Co., Ltd. announced its intention to withdraw from an M&A fund and related party transactions. The company has completed the recovery of its total paid-in capital from the investment. This decision aims to reduce management costs and focus on core business areas.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Proposed Withdrawal from an M&A Fund and Related Party Transactions

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Hunan Fangsheng Pharmaceutical Co., Ltd. on 6ix

Earlier from Hunan Fangsheng Pharmaceutical

Later from Hunan Fangsheng Pharmaceutical

All Hunan Fangsheng Pharmaceutical news releases